Literature DB >> 2787927

Binding properties of human anti-DNA antibodies to cloned human DNA fragments.

H Sano1, O Takai, N Harata, K Yoshinaga, I Kodama-Kamada, T Sasaki.   

Abstract

The DNA-anti-DNA antibody immune complexes were isolated from plasma of systemic lupus erythematosus (SLE) patients and DNA fragments separated from immune complexes were subjected to molecular cloning. The resulting recombinant DNA clones showed a molecular size of 37-79 base pairs, a high guanine and cytosine content, high frequencies of CpG dinucleotides, and palindromic sequences, and also clusters of G + C- and A + T-rich segments. These clones hybridized randomly to total human DNA. The reactivity of dsDNA antibodies, both monoclonal and polyclonal, from SLE was examined with a cloned SLE antigen DNA. A competitive inhibition assay showed that human monoclonal antibodies had at least one magnitude higher affinity to the cloned DNA than to the native DNA fragments. In order to characterize the factors that were recognized by antibodies, human G + C-rich and also A + T-rich 100 bp DNA fragments were cloned, and their base sequences determined. The antibody showed a higher affinity to the G + C-rich DNA fragment (71% G + C) than to the A + T-rich DNA fragment (46% G + C). When cytosines in CpG doublets in G + C-rich fragments were methylated (mCpG), the reactivity increased up to 100-fold. The native anti-DNA antibodies from SLE patients also showed preferential binding to G + C-rich fragments. These observations suggested that human anti-dsDNA antibodies may recognize some unique structures around the G + C regions or G + C clusters of DNA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2787927     DOI: 10.1111/j.1365-3083.1989.tb01188.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  18 in total

1.  Selective binding of anti-DNA antibodies to native dsDNA fragments of differing sequence.

Authors:  Melissa B Uccellini; Patricia Busto; Michelle Debatis; Ann Marshak-Rothstein; Gregory A Viglianti
Journal:  Immunol Lett       Date:  2012-01-21       Impact factor: 3.685

2.  Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells.

Authors:  H Vallin; S Blomberg; G V Alm; B Cederblad; L Rönnblom
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

3.  Lupus autoantibodies to native DNA preferentially bind DNA presented on PolIV.

Authors:  Sanjeev Kumar; Karen A Bunting; Jatinderpal Kalsi; John A Hinks; David S Latchman; Laurence H Pearl; David A Isenberg
Journal:  Immunology       Date:  2005-03       Impact factor: 7.397

4.  Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agents.

Authors:  Matlock A Jeffries; Amr H Sawalha
Journal:  Int J Clin Rheumtol       Date:  2011-08

Review 5.  Inflammasomes in the pathophysiology of autoinflammatory syndromes.

Authors:  Sarang Tartey; Thirumala-Devi Kanneganti
Journal:  J Leukoc Biol       Date:  2019-10-14       Impact factor: 4.962

6.  Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9.

Authors:  Terry K Means; Eicke Latz; Fumitaka Hayashi; Mandakolathur R Murali; Douglas T Golenbock; Andrew D Luster
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

Review 7.  Evolving story of autoantibodies in systemic lupus erythematosus.

Authors:  David S Pisetsky
Journal:  J Autoimmun       Date:  2019-12-04       Impact factor: 7.094

8.  Self double-stranded (ds)DNA induces IL-1β production from human monocytes by activating NLRP3 inflammasome in the presence of anti-dsDNA antibodies.

Authors:  Min Sun Shin; Youna Kang; Naeun Lee; Elizabeth R Wahl; Sang Hyun Kim; Ki Soo Kang; Rossitza Lazova; Insoo Kang
Journal:  J Immunol       Date:  2013-01-11       Impact factor: 5.422

Review 9.  CpG DNA: a pathogenic factor in systemic lupus erythematosus?

Authors:  A M Krieg
Journal:  J Clin Immunol       Date:  1995-11       Impact factor: 8.317

10.  Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexes.

Authors:  Kei Yasuda; Christophe Richez; Melissa B Uccellini; Rocco J Richards; Ramon G Bonegio; Shizuo Akira; Marc Monestier; Ronald B Corley; Gregory A Viglianti; Ann Marshak-Rothstein; Ian R Rifkin
Journal:  J Immunol       Date:  2009-07-31       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.